Drug profile · INN
samarium [153sm] lexidronam pentasodium
QUADRAMET
samarium [153sm] lexidronam pentasodium (QUADRAMET) is a unknown.
EMA: approved Various (V10) V10BX02
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — samarium [153sm] lexidronam pentasodium
- Class
- Various (V10)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
samarium [153sm] lexidronam pentasodium (QUADRAMET) is a unknown.
Key facts
INN samarium [153sm] lexidronam pentasodium
Brand QUADRAMET
Mechanism Unknown
Therapeutic class Various (V10)
ATC code V10BX02
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is samarium [153sm] lexidronam pentasodium?
samarium [153sm] lexidronam pentasodium (QUADRAMET) is a unknown.
What is the brand name for samarium [153sm] lexidronam pentasodium?
QUADRAMET is a marketed brand name for samarium [153sm] lexidronam pentasodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.